StockData
BioAdaptives, Inc. logo

BioAdaptives, Inc. (BDPT) stock

BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.00−0.00 (-5.56%)

Close on Oct 19, 2026Market cap $478.03KP/E –Yield –

BioAdaptives shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BioAdaptives's shares outstanding was 281M at Jun 30, 2026. For fiscal 2025 it was 10M, up 22.6% from the year before. The highest annual figure on record is 20M in fiscal 2020.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202510M+22.6%
FY2024Dec 31, 20248M+37.6%
FY2023Dec 31, 20236M-70.7%
FY2020Dec 31, 202020M+9.3%
FY2019Dec 31, 201919M+9.9%
FY2018Dec 31, 201817M+33.4%
FY2015Dec 31, 201513M+2.0%
FY2014Dec 31, 201412M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026281M+2849.6%
Q1 FY2026Mar 31, 202612M+32.7%
Q4 FY2025Dec 31, 202512M+21.4%
Q3 FY2025Sep 30, 202510M+24.7%
Q2 FY2025Jun 30, 202510M+219.3%
Q1 FY2025Mar 31, 20259M+17.5%
Q4 FY2024Dec 31, 202410M-98.6%
Q3 FY2024Sep 30, 20248M-75.7%
Q2 FY2024Jun 30, 20243M-91.0%
Q1 FY2024Mar 31, 20248M-72.7%
Q3 FY2023Sep 30, 2023730M+3429.4%
Q3 FY2021Sep 30, 202134M+62.6%
Q2 FY2021Jun 30, 202133M+66.6%
Q1 FY2021Mar 31, 202128M+48.6%
Q4 FY2020Dec 31, 202021M+9.5%
Q3 FY2020Sep 30, 202021M+11.1%
Q2 FY2020Jun 30, 202020M+6.8%
Q1 FY2020Mar 31, 202019M-16.3%
Q4 FY2019Dec 31, 201919M+3.5%
Q3 FY2019Sep 30, 201919M+13.0%
Q2 FY2019Jun 30, 201919M+10.0%
Q1 FY2019Mar 31, 201923M+59.5%
Q4 FY2018Dec 31, 201818M+28.7%
Q3 FY2018Sep 30, 201817M+23.0%
Q2 FY2018Jun 30, 201817M+32.5%
Q3 FY2016Sep 30, 201614M+11.3%
Q2 FY2016Jun 30, 201614M–
Q1 FY2016Mar 31, 201613M–
Q4 FY2015Dec 31, 201513M–
Q3 FY2015Sep 30, 201513M–

More BioAdaptives figures

See a number that looks wrong?